Company: JUNS
Filing Date: 2025-08-19
Form Type: 10-Q
Source: 0001641172-25-024684
Chunk: 13

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-08-19
Form: 10-Q
Item: Item 8
Chunk 13
---
 
  
    Less accumulated amortization 
     (189,360) 
     (166,367)
  
    Right-of-use asset, net 
    $46,649  
    $69,642 

Future
minimum lease liability payments under the non-cancelable operating lease at June 30, 2025 and December 31, 2024 are as follows:

Schedule
of Future Minimum Lease Liability Payments Under Non-cancelable Operating Lease

    2025 
    $25,327  
    $50,476 
  
    2026 
     21,290  
     21,290 
  
    Total lease payments 
     46,617  
     71,766 
  
    Less: imputed interest 
     (189) 
     (437)
  
    Total lease liabilities 
    $46,428  
    $71,329 

    Current operating lease liabilities 
     46,428  
     50,082 
  
    Non-current operating lease liabilities 
     -  
     21,247 
  
    Total lease liabilities 
    $46,428  
    $71,329 

    20

JUPITER
NEUROSCIENCES, INC.

NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE
30, 2025

Note
7 – Commitments and Contingencies, continued

Leases, continued

Short-term
rental costs expensed as incurred totaled $3,255 and $5,284 for the three and six months ended June 30, 2025, respectively, and totaled
$8,865 and $13,075 for the three and six months ended June 30, 2024, respectively, and is included in general and administrative expenses
on the accompanying condensed consolidated statements of operations.

Consulting
Agreements

The
Company utilizes various consultants and advisors for clinical research, scientific advisory services and business strategies. Each
consultant has an executed agreement in place defining term, compensation, duties, confidentiality, intellectual property. Agreements
are evaluated for renewal upon expiration. Bonus provisions are at the discretion of the Company’s Board of Directors and are
granted on an individual agreement basis.

On
December 15, 2024, the Company entered into a Strategic Services Agreement (the “Dominant Treasure Agreement”) with Dominant
Treasure Health Company Limited (“Dominant Treasure”).